vaginal diseases

Showing 1 - 11 of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bacterial Vaginosis, Vaginal Infection, Vaginal Diseases Trial in Czechia, Poland, Slovakia (Dequalinium Chloride, Metronidazole

Terminated
  • Bacterial Vaginosis
  • +2 more
  • Dequalinium Chloride
  • Metronidazole Oral
  • Brno, Czechia
  • +13 more
Mar 28, 2023

Atrophic Vaginitis, Vaginal Diseases Trial in Campinas (Health care product (intimate gel))

Completed
  • Atrophic Vaginitis
  • Vaginal Diseases
  • Health care product (intimate gel)
  • Campinas, SP, Brazil
    Allergisa Pesquisa Dermato-Cosmética Ltda
Jul 30, 2021

Vaginal Diseases Trial in Pulau Pinang (STP4 (product with probiotics), Placebo (product without probiotics))

Completed
  • Vaginal Diseases
  • STP4 (product with probiotics)
  • Placebo (product without probiotics)
  • Pulau Pinang, Penang, Malaysia
    School of Industrial Technology, Universiti Sains Malaysia
Apr 26, 2021

Atrophy, Vaginal Diseases Trial (Ospemifene (Dose 1), Ospemifene (Dose 2), Placebo)

Completed
  • Atrophy
  • Vaginal Diseases
  • Ospemifene (Dose 1)
  • +2 more
  • (no location specified)
Apr 19, 2018

Atrophy, Vaginal Diseases Trial (Ospemifene 60Mg Oral Tablet)

Completed
  • Atrophy
  • Vaginal Diseases
  • Ospemifene 60Mg Oral Tablet
  • (no location specified)
Apr 19, 2018

Atrophy, Vaginal Diseases Trial (Ospemifene 60 mg, Placebo)

Completed
  • Atrophy
  • Vaginal Diseases
  • Ospemifene 60 mg
  • Placebo
  • (no location specified)
Apr 19, 2018

Atrophy, Vaginal Diseases Trial (Ospemifene 60 mg, Placebo)

Completed
  • Atrophy
  • Vaginal Diseases
  • Ospemifene 60 mg
  • Placebo
  • (no location specified)
Apr 19, 2018

Vaginal Diseases Trial in Norfolk (Placebo Vaginal Insert)

Completed
  • Vaginal Diseases
  • Placebo Vaginal Insert
  • Norfolk, Virginia
    Eastern Virginia Medical School
Jun 1, 2016

Ureteral Stent Occlusion, Exposure Laser, Ureterostomy; Functional Disturbance Trial in Philadelphia (Desflurane, Sevoflurane)

Completed
  • Ureteral Stent Occlusion
  • +6 more
  • Philadelphia, Pennsylvania
    Hahnemann University Hospital
Nov 6, 2013

Atrophy, Vaginal Diseases Trial (Ospemifene 30 mg, Ospemifene 60 mg, Placebo)

Completed
  • Atrophy
  • Vaginal Diseases
  • Ospemifene 30 mg
  • +3 more
  • (no location specified)
May 21, 2013

Atrophy, Vaginal Diseases Trial (Placebo, Ospemifene 5 mg, Ospemifene 15 mg)

Completed
  • Atrophy
  • Vaginal Diseases
  • Placebo
  • +3 more
  • (no location specified)
May 21, 2013